Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Comment by juansitoon Nov 29, 2018 12:17pm
44 Views
Post# 29040094

RE:Hate To Break It To You Baggies

RE:Hate To Break It To You Baggies2 or 3 folks sold 
no panic selling
much expectation on future developement than in partner IMNP
that imo will still survive and go foward w Ico008 
but I always take out off the Ico value that venue...
is all about Ico019 from last year...
and yes they need or may not need a JV or PP
to complete phase 2 
and maybe they go foward by their own...and sp will recover...
why will be at 2?
<< Previous
Bullboard Posts
Next >>